ISRCTN72673620Recruiting未知
Manchester Asthma and Allergy Study
Wythenshawe Hospital (UK)0 sites1,250 target enrollmentStarted: May 5, 2006Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Recruiting
- Sponsor
- Enrollment
- 1,250
Study Overview
Brief Summary
2008 results in: http://www.ncbi.nlm.nih.gov/pubmed/18356563 2008 results in: http://www.ncbi.nlm.nih.gov/pubmed/20167852 2015 results in: http://www.ncbi.nlm.nih.gov/pubmed/25962900 2018 results in: https://www.ncbi.nlm.nih.gov/pubmed/30320550
Study Design
- Study Type
- Observational
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •Children born at Wythenshawe Hospital, Manchester and Stepping Hill Hospital, Stockport between January 1996 and April 1998
Exclusion Criteria
- •Premature birth <32 weeks gestation
Investigators
Similar Trials
Recruiting
Not Applicable
Manchester Asthma and Allergy Study - primary prevention of asthma and allergy by allergen avoidance in high risk infantsRespiratoryAsthmaISRCTN63558189Wythenshawe Hospital (UK)300
Completed
Not Applicable
Development of a coproduced, multifaceted intervention to optimise asthma management, tailored to the needs of children of South Asian origiAsthmaISRCTN32174198niversity of Leicester (UK)138
Active, not recruiting
Not Applicable
An Observational, Prospective, Multicenter Study to Evaluate the Biologic Use and Outcomes in Chinese Asthma PatientsAsthmaNCT06605885AstraZeneca202
Completed
Not Applicable
Real World and Genomic Data Based Asthma Insight Through Network AnalysisAsthmaNCT06623435Icahn School of Medicine at Mount Sinai1,075
Withdrawn
Phase 3
Effectiveness of Fluticasone Furoate/ Umeclidinium/ Vilanterol (FF/UMEC/VI) Using the Connected Inhaler System (CIS) as Compared With Fluticasone Proprionate/ Salmeterol (FP/SAL) Plus Tiotropium (TIO) in Inadequately Controlled AsthmaAsthmaNCT03376932GlaxoSmithKline